"NEW SECTION.  Sec. 5   By December 31st of each year, the department and the department of health shall publish a report identifying safer, technically feasible alternatives to commercial decabromodiphenylether for use in the state of Washington. This report shall include the relative measurements of persistence, toxicity, and bioaccumulation upon which the determination was made that the identified alternative is safer for human health and the environment. The report shall also include the analysis of market availability and price of the alternative upon which the determination that the alternative is technically feasible is made, along with the analysis of the economic viability of products containing these alternatives based on the price differential between commercial decabromodiphenylether and the identified alternative. If no safer, technically feasible alternatives are identified in the report, the department shall by rule grant an exemption to the ban such that a ban may not take effect until four years after the identification of safer, technically feasible alternatives to commercial decabromodiphenylether."